Zhou, Xujiao <br/><br/>
Alpha7 nicotinic acetylcholine receptor agonist promotes retinal ganglion cell function via modulating GABAergic presynaptic activity in a chronic glaucomatous model.  [electronic resource] 

 -  Scientific reports  05 2017 
 - 1734 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2045-2322 
<br/><br/><label>Standard No.: </label>10.1038/s41598-017-02092-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Benzamides--pharmacology<br/>Bridged Bicyclo Compounds--pharmacology<br/>Cell Survival--drug effects<br/>Chronic Disease<br/>Color Vision--drug effects<br/>Disease Models, Animal<br/>Down-Regulation--drug effects<br/>GABA Antagonists--pharmacology<br/>GABAergic Neurons--metabolism<br/>Glaucoma--metabolism<br/>Glutamate Decarboxylase--metabolism<br/>Inhibitory Postsynaptic Potentials--drug effects<br/>Kinetics<br/>Male<br/>Models, Biological<br/>Neuroprotective Agents--pharmacology<br/>Ocular Hypertension--metabolism<br/>Presynaptic Terminals--metabolism<br/>Pyridazines--pharmacology<br/>Rats, Wistar<br/>Retinal Ganglion Cells--metabolism<br/>alpha7 Nicotinic Acetylcholine Receptor--agonists<br/>gamma-Aminobutyric Acid--metabolism